Delivery Order SPE2DB24D6044-SPE2DB25FLHUM

Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,094.12 firm fixed-price delivery order is for the supply of PIPERACIL-TAZOBACT 3.375 GM VLS, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,313.72 firm fixed price delivery order is for PIPERACIL-TAZOBACT 3.375 GM VLS, a medical product. The contract has an ultimate completion date of April 20, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award, valued at $1,703.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4567731391 - PIPERACIL-TAZOBACT 3.375 GM VLS, with a completion date of March 31, 2025. This award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,179.39 firm fixed-price delivery order is for the supply of PIPERACIL-TAZO 4.5 GM ADD VIALS, a pharmaceutical product. The contract has an ultimate completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,475.05 delivery order contract is for the supply of PIPERACIL-TAZOBACT 3.375 GM VLS, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 15, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $2,548.62, is for the delivery of Piperacil-Tazobact 3.375 GM VLS, a pharmaceutical product, and is a Firm Fixed Price Delivery Order with a completion date of July 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,306.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of PIPERACIL-TAZOBACT 3.375 GM VLS, a pharmaceutical product. The award is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,381.21 firm fixed-price delivery order is for the supply of PIPERACIL-TAZOBACT 3.375 GM VLS, a pharmaceutical product, with an ultimate completion date of April 8, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,036.14 firm fixed-price delivery order is for the supply of PIPERACIL-TAZOBACT 3.375 GM VLS, a pharmaceutical product, with a performance period ending on March 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,176.15, is for the supply of Piperacil-Tazobact 3.375 GM vials to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the...
  • SPE2DB24D6044
    Indefinite Delivery Contract
  • SPE2DB24D6044-SPE2DB25FLHUM
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,212.71, is a Firm Fixed Price Delivery Order for the supply of PIPERACIL-TAZOBACT 3.375 GM VLS, a pharmaceutical product. The contract has an ultimate completion date of April 9, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 7/8/25, 2:17 PM